Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
qhpeptides.com
Samples
Passed
Failed
Trust score updated: May 28, 2026 · 100% pass rate
Composite score based on 27 COAs attributed to this vendor.
Mean HPLC purity across published COAs
Per-peptide coverage of identity / endotoxin / microbial / heavy-metals / net-content panels
Lab corroboration tier — confirmed via public verify portal (90), presumptive trusted lab (85), lab resolved but unverified (75), or no lab attribution (50)
| Date | Peptide | Test | Result | Purity | Lab | Notes |
|---|---|---|---|---|---|---|
| Apr 13, 2026 | Tirzepatide | HPLC purity | PASS | 99.644% | Janoshik Analytical | Lot 4 · Report 135076 |
| Apr 9, 2026 | Epithalon | HPLC purity | PASS | 99.623% | Janoshik Analytical | Lot 4 · Report 135096 |
| Apr 9, 2026 | Selank | HPLC purity | PASS | 99.871% | Janoshik Analytical | Lot 4 · Report 135072 |
We are continuously testing more products. Scores update with each new result.
Read our scoring methodology →Trust scores are computed from indexed Certificates of Analysis — vendor-published, and lab-confirmed where a lab copy verifies them — using a fixed, versioned methodology (v13). They are not based on independent blind-purchase testing, and no vendor can pay for placement or a higher score. How we score · How we make money
Inverse of CoaFlag count (lot collisions, hash collisions, etc.)
Composite of 27 COAs attributed to this vendor. Last recomputed 2026-05-28.
New domain (-0.06), No physical address (-0.03), Clean presence (0.03)
Sources: RDAP/WHOIS for domain data, Twilio Lookup for phone classification, Google Places for address verification. Crawl runs weekly. Signals are independent of vendor-supplied data.
| Apr 9, 2026 | PT-141 | HPLC purity | PASS | 99.923% | Janoshik Analytical | Lot 4 · Report 135084 |
| Apr 9, 2026 | GHK-Cu | HPLC purity | PASS | 99.598% | Janoshik Analytical | Lot 4 · Report 135104 |
| Apr 9, 2026 | MOTS-C | HPLC purity | PASS | 99.658% | Janoshik Analytical | Lot 4 · Report 135092 |
| Apr 9, 2026 | Cagrilintide | HPLC purity | PASS | 99.884% | Janoshik Analytical | Lot 4 · Report 135088 |
| Apr 9, 2026 | AOD-9604 | HPLC purity | PASS | 99.747% | Janoshik Analytical | Lot 4 · Report 135064 |
| Mar 16, 2026 | AOD-9604 | HPLC purity | PASS | 99.569% | Janoshik Analytical | Lot 3 · Report 113520 |
| Mar 16, 2026 | Tirzepatide | HPLC purity | PASS | 99.906% | Janoshik Analytical | Lot 3 · Report 113535 |
| Mar 16, 2026 | SS-31 | HPLC purity | PASS | 99.762% | Janoshik Analytical | Lot 3 · Report 113514 |
| Mar 16, 2026 | BPC-157 | HPLC purity | PASS | 99.586% | Janoshik Analytical | Lot 3 · Report 113526 |
| Mar 16, 2026 | 5-Amino-1mq | Identity & safety panels | PASS | -- | Janoshik Analytical | Lot 3 · Report 113508 |
| Mar 16, 2026 | CJC-1295 without DAC + Ipamorelin (CP10) | Identity & safety panels | PASS | -- | Janoshik Analytical | Lot 3 · Report 113517 |
| Mar 16, 2026 | Semaglutide | HPLC purity | PASS | 99.453% | Janoshik Analytical | Lot 3 · Report 113523 |
| Feb 19, 2026 | 5-amino-1mq | Identity & safety panels | PASS | -- | Janoshik Analytical | Lot 2 · Report 104635 |
| Feb 19, 2026 | Tirzepatide | HPLC purity | PASS | 99.901% | Janoshik Analytical | Lot 2 · Report 109708 |
| Feb 19, 2026 | NAD+ | Identity & safety panels | PASS | -- | Janoshik Analytical | Lot 2 · Report 104650 |
| Feb 19, 2026 | Retatrutide | HPLC purity | PASS | 99.814% | Janoshik Analytical | Lot 2 · Report 109683 |
| Feb 16, 2026 | BPC-157, TB-500, GHK-Cu, KPV | Identity & safety panels | PASS | -- | Janoshik Analytical | Lot 2 · Report 104629 |
| Feb 16, 2026 | SNAP-8 | HPLC purity | PASS | 99.821% | Janoshik Analytical | Lot 2 · Report 104641 |
| Feb 16, 2026 | Tesamorelin | HPLC purity | PASS | 99.74% | Janoshik Analytical | Lot 2 · Report 104638 |
| Feb 16, 2026 | CJC-1295 (mod GRF 1-29) + Ipamorelin blend | Identity & safety panels | PASS | -- | Janoshik Analytical | Lot 2 · Report 104647 |
| Feb 16, 2026 | BPC-157 + TB-500 blend | Identity & safety panels | PASS | -- | Janoshik Analytical | Lot 2 · Report 104632 |
| Feb 16, 2026 | SS-31 | HPLC purity | PASS | 99.751% | Janoshik Analytical | Lot 2 · Report 104644 |
| Jan 15, 2026 | Retatrutide | HPLC purity | PASS | 99.238% | Janoshik Analytical | Lot 12 · Report 99276 |
| Jan 15, 2026 | Tirzepatide | HPLC purity | PASS | 99.83% | Janoshik Analytical | Lot 12 · Report 99274 |